about_us

ABOUT US
ABOUT US

Kanghong is a company dedicated to improving public health
FOR EVERYONE
FOR EVERYONE

Improving the lives of patients through high quality, innovation, and responsibility
INNOVATION
INNOVATION

Kanghong is guided by an unwavering commitment to the highest standards .
- Clinical Trials and Results
- Research and Development
PRODUCTS
PRODUCTS

Kanghong discovers and develops high-quality medicines that benchmark against the most stringent international standards .
QUALITY
QUALITY

Kanghong focuses on high-quality medicines, that meet the most stringent laboratory, manufacturing and scientific standards.
INVESTOR
INVESTOR

Kanghong is committed to creating sustainable performance that benefits patients, employees, shareholders and society.
CAREER
CAREER

Welcome to join a diverse mix of people, who genuinely believe that our mission is to help people around the world live healthier lives.
- Jobs
- Work at Kanghong
MEDIA
MEDIA

Kanghong provides journalists with company and product news, as well as key facts, figures and background information.

ABOUT US
FOR EVERYONE
INNOVATION
- Clinical Trials and Results
- Research and Development
PRODUCTS
QUALITY
INVESTOR
CAREER
- Jobs
- Work at Kanghong
MEDIA
Feedback

follow the official account

“Current information on our scientific progress to bring forward a safe and effective vaccine.”

Home / About Us

Kanghong at A Glance

1996

Kanghong was founded in 1996
13 Subsidiaries

with 13 subsidiaries across
China, US and Israel
$ 457 Million

$457M revenue in 2019

Mission

Improving the lives of patients through high quality, innovation, and responsibility.

Stories

Chinese Social Welfare Enterprises

We provide access to healthcare for the underserved populations
Top 100 in the China's Pharmaceutical Industry

We are ranked among leading pharmaceutical companies in Mainland China
China Industry Awards

We take pride in our reliable manufacturing capacity

Where We Are

Chengdu（CHN） Beijing（CHN） Hong Kong（CHN） New Jersey（USA） Caesarea（ISR）

About IOPtima

IOPtima is a fast growing company, focusing on developing minimally invasive and innovative surgical ophthalmic devices.

IOPtima’s flagship product, the IOPtimate™, is a surgical system for the treatment of Glaucoma, which utilizes CO2 laser technology to significantly reduce internal eye pressure (“IOP”), without penetrating the eye.

We are an experienced and motivated team. We work towards realizing our vision is of introducing cutting- edge innovation and forefront technologies to the ophthalmic segment.

IOPtima is a Chengdu Kanghong Pharmaceutical company.